Showing results (61-70 of 73) with videos related to

Sort By:
Pageof 8
Frontiers in Cell and Developmental Biology|April 26, 2021
Selective Requirements for Vascular Endothelial Cells and Circulating Factors in the Regulation of Retinal NeurogenesisSusov Dhakal, Shahar Rotem-Bamberger, Josilyn R Sejd, et al.
Microorganisms|December 3, 2020
Comparative Analysis of the Global Transcriptomic Response to Oxidative Stress of <i>Bacillus anthracis</i> <i>htrA</i>-Disrupted and Parental Wild Type StrainsGalia Zaide, Uri Elia, Inbar Cohen-Gihon, et al.
Viruses|April 23, 2022
Phage Therapy Potentiates Second-Line Antibiotic Treatment against Pneumonic PlagueYaron Vagima, David Gur, Moshe Aftalion, et al.
Cells|August 25, 2019
Early Diagnosis of Pathogen Infection by Cell-Based Activation ImmunoassayErez Bar-Haim, Shahar Rotem, Uri Elia, et al.
Science Advances|March 8, 2023
A single-dose F1-based mRNA-LNP vaccine provides protection against the lethal plague bacteriumEdo Kon, Yinon Levy, Uri Elia, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|May 9, 2022
Immune Response to Third Dose BNT162b2 COVID-19 Vaccine Among Kidney Transplant Recipients-A Prospective StudyDafna Yahav, Ruth Rahamimov, Tiki Mashraki, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 8, 2014
Integrated strategy reveals the protein interface between cancer targets Bcl-2 and NAF-1Sagi Tamir, Shahar Rotem-Bamberger, Chen Katz, et al.
Pathogens (Basel, Switzerland)|August 28, 2021
Implementation of Adenovirus-Mediated Pulmonary Expression of Human ACE2 in HLA Transgenic Mice Enables Establishment of a COVID-19 Murine Model for Assessment of Immune Responses to SARS-CoV-2 InfectionTheodor Chitlaru, Erez Bar-Haim, Liat Bar-On, et al.
Nature Communications|April 26, 2022
Genome-wide CRISPR screens identify GATA6 as a proviral host factor for SARS-CoV-2 via modulation of ACE2Ma'ayan Israeli, Yaara Finkel, Yfat Yahalom-Ronen, et al.
Nano Letters|May 25, 2021
Lipid Nanoparticle RBD-hFc mRNA Vaccine Protects hACE2 Transgenic Mice against a Lethal SARS-CoV-2 InfectionUri Elia, Shahar Rotem, Erez Bar-Haim, et al.
Pageof 8